Campbell & CO Investment Adviser LLC decreased its holdings in shares of Catalyst Pharmaceuticals, Inc. () by 17.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.

Source: https://www.americanbankingnews.com/2023/06/11/campbell-co-investment-adviser-llc-sells-12653-shares-of-catalyst-pharmaceuticals-inc-nasdaqcprx.html

Cantor Fitzgerald increased their price objective on shares of Catalyst Pharmaceuticals from $22.00 to $25.00 in a research note on Friday, March 17th.

Source: https://www.etfdailynews.com/2023/06/10/commonwealth-of-pennsylvania-public-school-empls-retrmt-sys-grows-holdings-in-catalyst-pharmaceuticals-inc-nasdaqcprx/

Catalyst Pharmaceuticals, Inc. has a fifty-two week low of $5.58 and a fifty-two week high of $22.11.

Source: https://www.etfdailynews.com/2023/02/05/catalyst-pharmaceuticals-inc-nasdaqcprx-stake-lessened-by-russell-investments-group-ltd/

Finally, HC Wainwright boosted their price target on Catalyst Pharmaceuticals from $18.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, December 21st.

Source: https://www.etfdailynews.com/2023/01/31/barclays-plc-boosts-stake-in-catalyst-pharmaceuticals-inc-nasdaqcprx/

Finally, Truist Financial raised their target price on shares of Catalyst Pharmaceuticals from $22.00 to $24.00 in a report on Tuesday, June 20th.

Source: https://www.americanbankingnews.com/2023/07/22/catalyst-pharmaceuticals-nasdaqcprx-receives-buy-rating-from-hc-wainwright.html

In other Catalyst Pharmaceuticals news, insider sold 5,918 shares of the company’s stock in a transaction that occurred on Tuesday, December 6th.

Source: https://www.etfdailynews.com/2023/01/31/barclays-plc-boosts-stake-in-catalyst-pharmaceuticals-inc-nasdaqcprx/

Robeco Institutional Asset Management B.V.’s holdings in Catalyst Pharmaceuticals were worth $1,099,000 at the end of the most recent reporting period.

Source: https://www.etfdailynews.com/2023/08/06/robeco-institutional-asset-management-b-v-buys-11365-shares-of-catalyst-pharmaceuticals-inc-nasdaqcprx/

State Street Corp raised its position in shares of Catalyst Pharmaceuticals by 39.0% during the 3rd quarter.

Source: https://www.dailypolitical.com/2023/10/26/asset-management-one-co-ltd-buys-new-stake-in-catalyst-pharmaceuticals-inc-nasdaqcprx.html

Toth Financial Advisory Corp lifted its position in Catalyst Pharmaceuticals by 400.0% during the 1st quarter.

Source: https://www.americanbankingnews.com/2023/09/23/catalyst-pharmaceuticals-inc-nasdaqcprx-shares-bought-by-brookstone-capital-management.html